ASRM/LinkedIn
May 18, 2026, 11:17
ASRM Responds to Supreme Court Mifepristone Decision – ASRM
American Society for Reproductive Medicine – ASRM shared a post on LinkedIn:
“While not a final decision, ASRM is pleased that the Supreme Court’s ruling will allow patients continued access to mifepristone. As the case continues to unfold, ASRM urges the Court to respect scientific evidence and FDA authority.
See Dr. Brannigan’s full statement.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Jun 13, 2026, 15:58Sergei Gorlovetsky: Excited to Be Attending ESHRE 2026 in London as Part of Fertiligent AI
-
Jun 13, 2026, 15:50The Real Reason IVF Success Falls With Age – Fertility Plus
-
Jun 13, 2026, 15:15Marco Zaccaria: How to Use Power Doppler Ultrasound in Transvaginal Assessment of Uterine Fibroids
-
Jun 13, 2026, 14:42Nilofer Husain: ABHI Report Calls for Sustained Action on Women’s Health Inequalities
-
Jun 13, 2026, 14:29Christopher Robinson: SNRI vs SSRI and the Risk of Hypertensive Disorders of Pregnancy
-
Jun 12, 2026, 14:37ACOG Releases 2026 Maternal Immunization Schedule for Pregnant and Postpartum Patients – SMFM
-
Jun 12, 2026, 14:15Camille Clare: Representing Obstetrics and Gynecology at the AMA House of Delegates!
-
Jun 12, 2026, 14:13Amos Grünebaum: Balancing Autonomy and Safety in Freebirth Counseling!
-
Jun 12, 2026, 14:08Marco Zaccaria: How Do Elastic Centripetal Forces Lead to Dynamic Changes in the Myometrial Free Margin as Regards Submucous Myomas?